Abstract
The epidemiologic evidence linking cigarette smoking to coronary artery disease has been supported by multiple studies over a period of 30 years. Community based cohort studies such as the Framingham study have shown that cigarette smokers are at a markedly elevated risk of developing cardiovascular events. These studies have also shown that former cigarette smokers have a decline in the excess incidence over a period of several years to approach that of non-smoking populations. Uncertainty then appears to exist as to whether cigarette smokers are at increased risk of cardiovascular events solely because of acute effects of smoking or whether cigarette smoking is also a risk factor for atherosclerosis. Evidence that cigarette smoking is a risk factor for atherosclerosis comes from autopsy and cardiac catheterization laboratory. While not all of these studies show a relationship, the data do, for the most part, show a definite relationship between cigarette smoking and atherosclerosis. Catheterization and autopsy studies suffer from biases that prevent application of prediction models to the general population. However, the combined view of the community based, catheterization and autopsy studies supports a unifying hypothesis of acute effects that may lead to cardiovascular events in the setting of established vascular disease as well as vascular damage that may promote the development of atherosclerosis. Cessation of smoking will rapidly remove the acute effects, and may lead to inactivation of acute lesions. The underlying substrate of atherosclerosis and coronary obstructive lesions appears to be correlated with long term cigarette smoking.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hammond EC, Horn D. Smoking and death rates — report on forty-four months of follow-up of 187,783 men. II. Death rates by cause. JAMA, 166:1294–1308 (1958).
Kannel WB, McGee DL, Castelli WP. Latest perspective on cigarette smoking and cardiovascular disease: the Framingham Study. J. Cardiac Rehabil, 4:267–277 (1984).
Wilhelmsen L. Berglund G, Elmfeldt D. The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J, 7:279–288 (1986).
Pooling Project Research Group. Relationship of blood pressure, serum cholesterol, smoking habit, relative weight and ECG abnormalities to incidence of major coronary events: final report of the Pooling Project. J Chronic Dis, 31:201–306 (1978).
Keys A, Taylor HL, Blackburn H, Brozek H, Anderson JT, Simonson E. Coronary heart disease among Minnesota business and professional men followed fifteen years. Circulation, 28:381–395 (1963).
Jenkins CD, Rosenman RH, Zyzanski SJ. Cigarette smoking: Its relationship to coronary heart disease and related risk factors in the Western Collaborative Group Study. Circulation, 38:1140–1154 (1968).
Doll R. Peto R. Mortality in relation to smoking: 20 year’sobservations of make British doctors. Br Med J, 2:1525–1536 (1976).
Hagman M, Wilhelmsen L, Wedel H, Pennert K. Risk factors for angina pectoris in a population sample of Swedish men. J Chronic Dis, 40:265–275 (1987).
Kannel WB, McGee D, Gordon T. A general cardiovascular risk profile: The Framingham Study. Am J Cardiol, 38:46–51 (1976).
Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies for smoking. Am Heart J, 115:242–249 (1988).
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Arch Intern Med, 148:36–39 (1988).
Wilhelmsson C, Elmfeldt D, Vedin JA, Tibblin G, Wihelmsen F. Smoking and myocardial infarction. Lancet, 1:415–420 (1975).
Aberg A, Bergstrand R. Hohansson S. Cessation of smoking after myocardial infarction — effects on mortality after 10 years. Br Heart J, 49:416–422 (1983).
Mulcahy R, Hickey N, Graham I, McKenzie G. Factors influencing long-term prognosis in male patients surviving a first coronary attack. Br Hear J, 37:158–165 (1975).
Mulcahy R. Influence of cigarette smoking on morbidity and mortality after myocardial infarction. Br Heart J, 49:410–415 (1983).
Sparrow D, Dawber TR, Colton T. The influence of cigarette smoking on prognosis after a first myocardial infarction. J Chronic Dis, 31:425–432 (1978).
Pohjola S, Siltanen P, Romo M. Effect of quitting smoking on the long-term survival after myocardial infarction (abstract) Trans Eur Soc Cardiol, 1:2 (1979).
Salonen JT. Stopping smoking and long-term mortality after acute myocardial infarction. Br Heart J, 43:463–469 (1980).
Rose G, Hamilton PJS, Colwell L, Shipley MJ. A randomized controlled trial of anti-smoking advice: 10 year results. J Epidemiol Community Health, 36:102–108 (1982).
Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med, 299:926–930 (1978).
Weintraub WS, Klein LW, Seelaus PA, Agarwal JB, Helfant RH. Importance of total life consumption of cigarettes as a risk factor for coronary artery disease. Am J Cardiol, 55:669–672 (1985).
Vlietstra RE, Frye RL, Kronmal RA, Sim DA, Tristani FE, Killip T. Risk factors and angiographic coronary artery disease: a report from the Coronary Artery Surgery Study (CASS). Circulation, 62:254–261 (1980).
Holmes DR, Elveback LR, Frye RL, Kottke BA, Ellefson RD. Association of risk factor variables and coronary artery disease documented with angiography. Circulation, 63:293–299 (1981).
Haapanen A, Koskenvuo M, Kaprio J, Kesaniemi YA, Heikkila K. Carotid arteriosclerosis in identical twins discordant for cigarette smoking. Circulation, 80:10–16 (1989).
Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med, 273:775–779 (1965).
Auerbach O, Carter HW, Garfinkel L, Hammond EC. Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest, 70:697–705 (1976).
Viel B, Donoso S, Salcedo D. Coronary atherosclerosis in persons dying violently. Arch Intern Med, 122:97–103 (1968).
Holme I, Enger SC, Helgeland A. Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Statistical analysis form the Oslo study. Arteriosclerosis, 1:250–256 (1981).
Sorlie PD, Garcia-Palmieri MR, Castillo-Staab MI, Costas JR R, Oalmann MC, Havlik R. The relation of antemortem factors to atherosclerosis at autopsy: The Puerto Rico Heart Health Program. Am J Pathol, 103:345–352 (1981).
Strong JP, Richards ML. Cigarette smoking and atherosclerosis in autopsied med. Atherosclerosis, 70:697–705 (1976).
Lifsic AM. Atherosclerosis in smokers. Bull WHO, 53:631–638 (1976).
Rhoads GG, Blackwelder WC, Stemmermann GN, Hayashi T, Kagan A. Coronary risk factors and autopsy findings in Japanese-American men. Lab Invest, 38:304–311 (1978).
Sternby NIH. Atherosclerosis, smoking and other risk factors. In: Gotto JR AM, Smith LC, Allen B, eds. International Symposium on Atherosclerosis, 5th, Houston, Texas, November 6–9, 1979, Proceedings; Atherosclerosis V. New York: Springer-Verlag, 67–70 (1980).
Klein LW, Ambrose J, Pichard A, Holt J, Gorlin R, Teichholz LE. Acute coronary hemodynamic response to cigarette smoking in patients with coronary artery disease. JACC, 3:879–886 (1984).
Glynn MF, Mustard JL, Buchanan JL, Murphy EA. Cigarette smoking and platelet aggregation. Can Med Assoc J, 95:549–553 (1966).
Ogston D, Bennett NB, Ogston CM. The influence of cigarette smoking on the plasma fibrinogen concentration. Atherosclerosis, 11:349–352 (1970).
Trap-Jensen J. Effects of smoking on the heart and peripheral circulation. Am Heart J, 115:263–267 (1988).
Mjos 0D. Lipid effects of smoking. Am Heart J, 115:272–275 (1988).
Goldbourt U, Medalie JH. Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic biochemical and genetic characteristics. Am J Epidemiol, 105:75–86 (1977).
Garrison RJ, Kannel WB, Feinleib M, Castelli WP, McNamara PM, Padgett SJ. Cigarette smoking and HDL cholesterol. The Framingham Offspring Study. Atherosclerosis, 30:17–25 (1978).
Howell RW. Smoking habits and laboratory tests. Lancet, 2:152 (1970).
Corre F, Lellouch J, Schwartz D. Smoking and leukocyte-counts. Results of an epidemiological survey. Lancet, 2:632–634 (1971).
Friedman GD, Siegelaub AB, Seltzer CC, Feldman R, Collen MF. Smoking habits and the leukocyte count. Arch Environ Health, 26:137–143 (1973).
Pecora MJ, Roubin GS, Cobbs BW, Weintraub W, King SB. Myocardial infarction in the absence of angiographically significant coronary atherosclerotic disease: long-term prognosis. Am J Cardiol, 62:363–367 (1988).
FitzGerald GA, Oates JA, Nowak J. Cigarette smoking and hemostatic function. Am Heart J, 115:267–271 (1988).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Weintraub, W.S. (1990). Cigarette Smoking as a Risk Factor for Coronary Artery Disease. In: Diana, J.N. (eds) Tobacco Smoking and Atherosclerosis. Advances in Experimental Medicine and Biology, vol 273. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5829-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5829-9_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5831-2
Online ISBN: 978-1-4684-5829-9
eBook Packages: Springer Book Archive